ASH24: Jennifer Brown, MD | Dana-Farber Cancer Institute
HTML-код
- Опубликовано: 2 янв 2025
- Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.
Read more: bit.ly/3OOgPNj
Video published 12/18/2024